The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn remedy causes cancer
More Stories
Tilray’s stock gains after earnings and upbeat outlook on cannabis legalization
Tilray’s stock gained Thursday, after the cannabis and beverage company reported a smaller loss than expected for its fiscal first...
Retail investor hype for AI stocks seems to be slowing down
Trading volumes for many AI stocks peaked earlier this year, and fell dramatically since.
Jobless claims surge to highest level in more than a year
The number of Americans who applied for unemployment benefits surged by 33,000 to 258,000 in the week ended October 5,...
Social Security’s COLA will be 2.5% in 2025, down from 3.2% in 2024
COLA helps the roughly 67 million Social Security beneficiaries keep up with inflationary pressures
Why PayPal’s stock just got downgraded in the face of this year’s strong rally
A Bernstein analyst sees a “wider-than-usual range of long-term outcomes for this company” as PayPal navigates competitive pressures.
What if Warren Buffett had faced Kamala Harris’s unrealized capital tax gains from the outset? Here are the numbers.
One fund manager calculated the ‘mad’ idea of imposing unrealized capital gains taxes on Warren Buffett.